Entropy Technologies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
+11,050
New +$11.2M 0.47% 53
2025
Q3
Sell
-1,503
Closed -$1.17M 968
2025
Q2
$1.17M Buy
+1,503
New +$1.17M 0.09% 273
2025
Q1
Sell
-8,141
Closed -$6.28M 858
2024
Q4
$6.28M Buy
8,141
+4,329
+114% +$3.58M 0.65% 20
2024
Q3
$3.38M Sell
3,812
-224
-6% -$201K 0.35% 77
2024
Q2
$3.65M Buy
+4,036
New +$3.23M 0.39% 66

Other funds holding LLY

Entropy Technologies's LLY Position: Q1 2026 in Review

Entropy Technologies opened a new position in Eli Lilly (LLY) in Q1 2026: 11,050 shares worth $10.2M. The stake represents 0.47% of the portfolio and ranks #53 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in LLY as recently as Q2 2025.

Entropy Technologies first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Entropy Technologies held 11,050 shares of Eli Lilly worth $10.2M as of Q1 2026.
  • Eli Lilly was a new Entropy Technologies position in Q1 2026.
  • Eli Lilly made up 0.47% of Entropy Technologies's portfolio in Q1 2026, its #53 holding.
  • Entropy Technologies first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.